ASSESSMENT OF THE DIFFERENCES IN PHARMACOKINETICS AND PHARMACODYNAMICS BETWEEN FOUR DISTINCT FORMULATIONS OF TRIAMCINOLONE ACETONIDE - Concepedia

Concepedia

Publication | Closed Access

ASSESSMENT OF THE DIFFERENCES IN PHARMACOKINETICS AND PHARMACODYNAMICS BETWEEN FOUR DISTINCT FORMULATIONS OF TRIAMCINOLONE ACETONIDE

47

Citations

37

References

2012

Year

Leandro Cabral Zacharias, Ton Lin, Rafael Migon, Corine Ghosn, Werhner Orilla, Barbara Feldmann, Guadalupe Ruíz, Yong Li, James R. Burke, Baruch D. Kuppermann

Abstract

Triamcinolone acetonide formulations do not have the same pharmacokinetics/pharmacodynamics. Kenalog has the longest vitreous visibility and durability. Particle size appears to correlate with efficacy and durability.

References

	Year	Citations
Intravitreal Injection of Triamcinolone for Diffuse Diabetic Macular Edema Jost B. Jonas Archives of Ophthalmology	2003	566
Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection Paul M. Beer, Sophie J. Bakri, Ravinder J. Singh, Ophthalmology Vitreous BodyOphthalmologyExperimental OphthalmologyMedicineSingle Intravitreal Injection	2003	564
A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Focal/Grid Photocoagulation for Diabetic Macular Edema Ophthalmology Diabetic RetinopathyOcular DiseaseVitreous BodyOphthalmologyDiabetes	2008	542
A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Standard Care to Treat Vision Loss Associated With Macular Edema Secondary to Branch Retinal Vein Occlusion Archives of Ophthalmology	2009	428
Intravitreal triamcinolone acetonide for diabetic diffuse macular edema11The authors have no proprietary interest in this study. 22Dr Audren, co–first author, contributed equally to the work. Pascale Massin, F. Audren, Belkacem Haouchine, Ophthalmology Diabetic RetinopathyOcular DiseaseVitreous BodyOphthalmologyIntravitreal Triamcinolone Acetonide	2004	419
Safety of an Intravitreal Injection of Triamcinolone Mark C. Gillies Archives of Ophthalmology	2004	295
TRIAMCINOLONE ACETONIDE AS AN AID TO VISUALIZATION OF THE VITREOUS AND THE POSTERIOR HYALOID DURING PARS PLANA VITRECTOMY Gholam A. Peyman, Rizwan A. Cheema, Mandi D. Conway, Retina Vitreous BodyComparative LiteratureOphthalmologyOculoplasticsMedicine	2000	287
INFECTIOUS AND PRESUMED NONINFECTIOUS ENDOPHTHALMITIS AFTER INTRAVITREAL TRIAMCINOLONE ACETONIDE INJECTION Mark L. Nelson, Matthew Tennant, Arunan Sivalingam, Retina	2003	257
Intravitreal triamcinolone and elevated intraocular pressure R J B Wingate Fracs, P E Beaumont Fracs Australian and New Zealand Journal of Ophthalmology	1999	246
Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood–retinal and blood–aqueous barrier breakdown Jeffrey L. Edelman, David J. Lutz, Marisol R. Castro Experimental Eye Research InflammationOphthalmologyVegf-induced Vascular LeakageExperimental OphthalmologyPhysiology	2004	243

Page 1